ENTA - Enanta Pharmaceuticals Inc.'s (ENTA) CEO Jay Luly on Q3 2021 Results - Earnings Call Transcript

Enanta Pharmaceuticals, Inc. (ENTA) Q3 2021 Earnings Conference Call August 5, 2021, 4:30 PM ET Company Participants Jennifer Viera - Investor Relations Dr. Jay Luly - President and CEO Paul Mellett - Chief Financial Officer Nathalie Adda - Chief Medical Officer Conference Call Participants Brian Skorney - Baird Swapnil Malekar - Piper Sandler Brian Abrahams - RBC Capital Markets Roy Buchanan - JMP Securities Zegbeh Jallah - ROTH Capital Markets Presentation Operator Good afternoon. And welcome to Enanta Pharmaceuticals Fiscal Third Quarter 2021 Financial Results Conference Call. At this time, all participants are in listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded. I would now like to turn the call over to Jennifer Viera, Investor Relations. Please go ahead. Jennifer Viera Thank you, Operator, and thanks to everyone for joining us this afternoon. The

For further details see:

Enanta Pharmaceuticals, Inc.'s (ENTA) CEO Jay Luly on Q3 2021 Results - Earnings Call Transcript